What are the criteria for septal alcohol ablation in hypertrophic obstructive cardiomyopathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Septal Alcohol Ablation Criteria in Hypertrophic Obstructive Cardiomyopathy

Alcohol septal ablation should be performed only in adult patients with obstructive HCM who meet three specific criteria: severe drug-refractory symptoms (NYHA class III-IV), LVOT gradient ≥50 mmHg, and adequate septal thickness for safe ablation, performed exclusively at experienced HCM centers. 1

Mandatory Eligibility Criteria

All three criteria must be met simultaneously 1:

1. Clinical Criteria

  • Severe dyspnea or chest pain (typically NYHA functional class III or IV) 1
  • Occasionally other exertional symptoms (syncope or near-syncope) that interfere with everyday activity or quality of life 1
  • Symptoms must persist despite optimal medical therapy (maximized beta-blockers, calcium channel blockers, or disopyramide) 1

2. Hemodynamic Criteria

  • Dynamic LVOT gradient ≥50 mmHg at rest or with physiologic provocation 1
  • Must be associated with septal hypertrophy and systolic anterior motion (SAM) of the mitral valve 1

3. Anatomic Criteria

  • Targeted anterior septal thickness sufficient to perform the procedure safely and effectively in the operator's judgment 1
  • The procedure is generally discouraged in patients with marked septal hypertrophy >30 mm due to uncertain effectiveness 1

Specific Indications by Clinical Context

Class I Indication (Recommended)

Alcohol septal ablation is recommended when: 1

  • Surgery is contraindicated OR
  • Surgical risk is unacceptable due to serious comorbidities or advanced age 1
  • Patient meets all three eligibility criteria above 1

Class IIb Indication (May Be Considered)

Alcohol septal ablation may be considered as an alternative to surgical myectomy when: 1

  • Patient meets all eligibility criteria 1
  • After balanced and thorough discussion, patient expresses preference for septal ablation over surgery 1
  • Performed at experienced HCM centers 1

Absolute Contraindications (Class III: Harm)

Do NOT perform alcohol septal ablation in: 1

  1. Patients <21 years of age (contraindicated) 1
  2. Adults <40 years of age if myectomy is viable (discouraged) 1
  3. Asymptomatic patients with normal exercise tolerance 1
  4. Patients with controlled symptoms on optimal medical therapy 1
  5. Patients with concomitant cardiac disease requiring surgical correction (e.g., multivessel CAD requiring CABG, mitral valve disease requiring repair, valvular aortic stenosis) where surgical myectomy can be performed simultaneously 1

Center and Operator Requirements

Critical caveat: Alcohol septal ablation must only be performed at experienced HCM centers with demonstrated excellence 1:

  • Individual operator: Cumulative case volume of ≥20 procedures 1
  • OR working in dedicated HCM program: Cumulative total of ≥50 procedures 1
  • Center volume >50 patients is an independent predictor of superior outcomes 2
  • Must be part of a comprehensive HCM clinical program with longitudinal multidisciplinary care 1

Target Outcomes for Quality Centers

Expected outcomes at experienced centers: 1

  • 30-day mortality: ≤1% 1
  • Complete heart block requiring permanent pacemaker: ≤10% 1
  • Symptomatic improvement (≥1 NYHA class): >90% 1
  • Rest and provoked LVOT gradient <50 mmHg: >90% 1
  • Repeat procedure rate: ≤10% 1

Predictors of Optimal Outcomes

Patients most likely to benefit from alcohol septal ablation have: 2

  • Age ≥65 years 2
  • LVOT gradient <100 mmHg 2
  • Septal hypertrophy ≤18 mm 2
  • Left anterior descending artery diameter <4.0 mm 2

Patients with ≥3 of these characteristics achieve 90.4% 4-year survival free of death and severe symptoms, compared to 57.5% in those with ≤1 characteristic. 2

Important Clinical Pitfalls

  • Never perform alcohol septal ablation outside a dedicated HCM program 1
  • Surgical myectomy remains the first consideration for most eligible patients, particularly younger patients without surgical contraindications 1
  • Consultation with centers offering both surgical myectomy and alcohol ablation is reasonable to ensure patients understand all treatment options 1
  • Distal obstruction after repeat ablation is associated with more frequent fatal arrhythmias and need for third interventions compared to proximal obstruction 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Predictors of an optimal clinical outcome with alcohol septal ablation for obstructive hypertrophic cardiomyopathy.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.